With respect to 150 NSCLCs, 28 tumours (35.4%) were N-cadherin-positive among the 79 E-cadherin-positive carcinomas, while 18 tumours (25.4%) were N-cadherin-positive among the 71 E-cadherin-negative carcinomas. This evidence concerns the gene CDH1 and neoplasm.